Hospital
Petersburg Hospital Company LLC
Petersburg Hospital Company LLC was paid $11.20M by Medicaid between Jan 2018 and Dec 2019, across 245 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoPETERSBURG HOSPITAL COMPANY LLC
PETERSBURG, VA 23805
PETERSBURG, VA 23805
33aNPI1104899319assigned 02/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.20M
24GClaims412,309
24DCodes billed245
24AFirst – last monthJan 2018 – Dec 2019
Compared with peers
Next to other General Acute Care Hospital providers in Virginia
Rank by total paid#48 of 80
Median peer was paid$14.69M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 170,447 | $4.07M | |
| 2019 | 241,862 | $7.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 21,877 | 18,271 | $2.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 15,703 | 12,345 | $1.70M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.7% | 6,046 | 4,651 | $857K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.7% | 8,993 | 6,510 | $754K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 3,960 | 3,038 | $504K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.3% | 1,615 | 1,339 | $374K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 4,112 | 3,641 | $373K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.2% | 1,861 | 1,461 | $360K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 3.0% | 2,667 | 2,144 | $337K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.4% | 2,405 | 1,843 | $271K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 5,328 | 1,111 | $222K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.5% | 1,771 | 870 | $171K |
233 more codes
| 93458 | 1.4% | 158 | $154K | |
| G0378 | Hospital observation service, per hour | 1.3% | 2,781 | $151K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 20,740 | $145K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 534 | $144K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 4,063 | $139K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.2% | 659 | $133K |
| 80053 | Comprehensive metabolic panel | <1% | 17,356 | $107K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 647 | $102K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 582 | $99K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 951 | $90K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,443 | $85K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 593 | $72K |
| 11043 | <1% | 336 | $72K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 874 | $69K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 329 | $67K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,159 | $64K |
| 93971 | <1% | 690 | $61K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,013 | $52K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,675 | $51K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,217 | $49K |
| 76642 | <1% | 644 | $49K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,542 | $48K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 788 | $48K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 188 | $47K |
| 84484 | <1% | 10,082 | $47K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 569 | $46K |
| 72131 | <1% | 341 | $30K | |
| 76770 | <1% | 427 | $29K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 55 | $28K |
| 83880 | <1% | 5,580 | $27K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 419 | $27K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 285 | $27K |
| 93970 | <1% | 308 | $23K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 742 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,770 | $22K |
| 11045 | <1% | 126 | $22K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,422 | $21K |
| 77336 | <1% | 52 | $21K | |
| 76801 | <1% | 582 | $20K | |
| 87040 | <1% | 2,250 | $19K | |
| 74420 | <1% | 94 | $19K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,028 | $18K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,632 | $18K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 237 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,274 | $16K |
| 74018 | <1% | 1,225 | $16K | |
| 12001 | <1% | 74 | $16K | |
| 52005 | <1% | 27 | $16K | |
| 81001 | <1% | 14,592 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,671 | $12K |
| 97163 | <1% | 319 | $12K | |
| 86850 | <1% | 1,523 | $12K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 51 | $12K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 193 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,497 | $11K |
| 77065 | Tomosynthesis, mammo | <1% | 338 | $11K |
| 72110 | <1% | 598 | $10K | |
| 82962 | <1% | 7,615 | $10K | |
| 73564 | <1% | 1,061 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,353 | $10K |
| 71250 | <1% | 243 | $9K | |
| 73610 | <1% | 766 | $9K | |
| 70486 | <1% | 233 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,765 | $8K |
| 73030 | <1% | 968 | $8K | |
| 77066 | Tomosynthesis, mammo | <1% | 268 | $8K |
| 73130 | <1% | 660 | $7K | |
| 10060 | <1% | 32 | $7K | |
| 87641 | <1% | 795 | $7K | |
| 90715 | <1% | 644 | $7K | |
| 73630 | <1% | 796 | $7K | |
| 36430 | <1% | 317 | $6K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 78 | $6K |
| 12011 | <1% | 44 | $6K | |
| 83605 | <1% | 1,641 | $6K | |
| 93017 | <1% | 68 | $6K | |
| 97010 | <1% | 1,004 | $6K | |
| 97161 | <1% | 355 | $5K | |
| 73502 | <1% | 795 | $5K | |
| 84703 | <1% | 3,623 | $5K | |
| 43235 | <1% | 16 | $5K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,214 | $5K |
| 85379 | <1% | 930 | $5K | |
| 29581 | <1% | 28 | $5K | |
| 84702 | <1% | 1,318 | $5K | |
| 82553 | <1% | 1,892 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 294 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,258 | $4K |
| 87807 | <1% | 805 | $4K | |
| 80061 | Lipid panel | <1% | 1,108 | $4K |
| 87077 | <1% | 2,144 | $4K | |
| J3490 | Unclassified drugs | <1% | 16,563 | $3K |
| 29125 | <1% | 14 | $3K | |
| 85027 | <1% | 3,077 | $3K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 21 | $3K |
| 73110 | <1% | 404 | $3K | |
| 86901 | <1% | 2,058 | $3K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 609 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,760 | $3K |
| 81025 | <1% | 3,099 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,363 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,697 | $3K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 144 | $3K |
| 85610 | <1% | 3,459 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 18 | $2K |
| 72100 | <1% | 215 | $2K | |
| 93880 | <1% | 47 | $2K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 373 | $2K |
| 88307 | <1% | 122 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,242 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,892 | $2K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 355 | $2K |
| 76870 | <1% | 27 | $2K | |
| 83690 | <1% | 3,962 | $2K | |
| 84145 | <1% | 185 | $2K | |
| 73140 | <1% | 129 | $2K | |
| 87186 | <1% | 2,031 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 197 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,316 | $1K |
| 80069 | <1% | 309 | $1K | |
| 85730 | <1% | 2,186 | $1K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 319 | $1K |
| 97014 | <1% | 103 | $1K | |
| 72050 | <1% | 131 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 696 | $1K |
| 95816 | <1% | 16 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 211 | $976.19 |
| 92610 | <1% | 41 | $950.82 | |
| 81003 | <1% | 1,810 | $928.26 | |
| 87070 | <1% | 958 | $926.71 | |
| 82550 | <1% | 2,644 | $888.61 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $795.59 |
| 73090 | <1% | 140 | $794.90 | |
| 84132 | <1% | 598 | $783.14 | |
| 73562 | <1% | 59 | $777.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,782 | $744.67 |
| 93923 | <1% | 14 | $735.74 | |
| 83735 | <1% | 1,496 | $634.66 | |
| 87210 | <1% | 972 | $624.41 | |
| 86900 | <1% | 2,058 | $566.36 | |
| 99152 | <1% | 601 | $516.97 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 16 | $508.20 |
| 87808 | <1% | 1,023 | $470.39 | |
| 82248 | <1% | 3,502 | $445.34 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,350 | $443.56 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,387 | $438.73 |
| 72072 | <1% | 53 | $430.87 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,873 | $416.46 |
| 97116 | <1% | 15 | $367.62 | |
| 97165 | <1% | 35 | $365.68 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 14 | $347.92 |
| 97162 | <1% | 20 | $335.48 | |
| 96367 | <1% | 16 | $333.75 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 74 | $333.27 |
| 77061 | <1% | 12 | $289.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,035 | $288.79 |
| 86140 | <1% | 80 | $284.79 | |
| 94729 | <1% | 14 | $272.75 | |
| 82565 | <1% | 223 | $265.13 | |
| 80076 | <1% | 65 | $260.96 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 703 | $237.23 |
| 73590 | <1% | 98 | $235.66 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 427 | $226.15 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 239 | $202.97 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,535 | $201.80 |
| 70360 | <1% | 14 | $200.97 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,572 | $198.63 |
| 73080 | <1% | 118 | $180.28 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 50 | $175.72 |
| 71101 | <1% | 43 | $175.22 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,814 | $167.04 |
| 96376 | <1% | 693 | $165.85 | |
| 85652 | <1% | 270 | $151.85 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,392 | $151.40 |
| 84520 | <1% | 153 | $142.45 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,796 | $135.76 |
| 84112 | <1% | 14 | $125.32 | |
| 73060 | <1% | 15 | $114.97 | |
| 80164 | <1% | 19 | $111.41 | |
| 88304 | <1% | 137 | $109.53 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,052 | $97.56 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 889 | $95.53 |
| 82805 | <1% | 351 | $92.10 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 512 | $86.48 |
| 73552 | <1% | 20 | $86.13 | |
| 84100 | <1% | 592 | $83.06 | |
| 94760 | <1% | 839 | $80.04 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 763 | $78.32 |
| 82607 | <1% | 107 | $72.61 | |
| 85018 | <1% | 159 | $70.59 | |
| 85014 | <1% | 121 | $70.08 | |
| 90686 | <1% | 18 | $63.10 | |
| 86920 | <1% | 305 | $58.67 | |
| 87205 | <1% | 124 | $56.24 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 494 | $47.93 |
| 82140 | <1% | 57 | $46.73 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | <1% | 17 | $46.41 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 611 | $42.10 |
| 80177 | <1% | 13 | $39.00 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 513 | $38.43 |
| 84550 | <1% | 81 | $34.07 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 267 | $24.45 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 390 | $23.91 |
| 88312 | <1% | 92 | $16.42 | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 182 | $15.36 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 114 | $12.20 |
| 82570 | <1% | 36 | $11.47 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 58 | $10.30 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | <1% | 122 | $10.25 |
| J2704 | Injection, propofol, 10 mg | <1% | 3,491 | $10.14 |
| 82150 | <1% | 107 | $9.88 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 381 | $8.46 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 69 | $2.97 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 45 | $2.55 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 16 | $1.54 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 43 | $1.15 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 17 | $1.11 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 272 | $0.00 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 15 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 114 | $0.00 |
| 51702 | 0% | 35 | $0.00 | |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 0% | 110 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 33 | $0.00 |
| 82010 | 0% | 28 | $0.00 | |
| 71010 | 0% | 28 | $0.00 | |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 110 | $0.00 |
| C1769 | Guide wire | 0% | 829 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 113 | $0.00 |
| 77417 | 0% | 178 | $0.00 | |
| G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 18 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 53 | $0.00 |
| 51725 | 0% | 33 | $0.00 | |
| 71020 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.